Universidad de Granada Digibug
 

Repositorio Institucional de la Universidad de Granada >
1.-Investigación >
Departamentos, Grupos de Investigación e Institutos >
Departamento de Química Física >
DQF - Artículos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10481/45202

Title: Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates
Authors: Bekri, Selma
Bourdely, Pierre
Luci, Carmelo
Dereuddre-Bosquet, Nathalie
Su, Bin
Martinon, Fréderic
Braud, Véronique M.
Luque Fernández, Irene
Mateo Alarcón, Pedro Luis
Crespillo, Sara
Conejero-Lara, Francisco
Moog, Christiane
Grand, Roger Le
Anjuère, Fabienne
Issue Date: 2017
Abstract: Persistent B cell responses in mucosal tissues are crucial to control infection against sexually transmitted pathogens like human immunodeficiency virus 1 (HIV-1). The genital tract is a major site of infection by HIV. Sublingual (SL) immunization in mice was previously shown to generate HIV-specific B cell immunity that disseminates to the genital tract. We report here the immunogenicity in female cynomolgus macaques of a SL vaccine based on a modified gp41 polypeptide coupled to the cholera toxin B subunit designed to expose hidden epitopes and to improve mucosal retention. Combined SL/intramuscular (IM) immunization with such mucoadhesive gp41-based vaccine elicited mucosal HIV-specific IgG and IgA antibodies more efficiently than IM immunization alone. This strategy increased the number and duration of gp41-specific IgA secreting cells. Importantly, combined immunization improved the generation of functional antibodies 3 months after vaccination as detected in HIV-neutralizing assays. Therefore, SL immunization represents a promising vaccine strategy to block HIV-1 transmission.
Sponsorship: These studies were supported by Institut National de la Santé et de la Recherche Médicale (INSERM, France) by Centre National de Recherche Scientifique (CNRS, France), by the Agence Nationale de Recherche sur le SIDA (France), the SIDACTION (France), by the Euroneut-41 European Consortium (FP7 program), by the National Research Agency (ANR) through the “Investments for the Future” LABEX SIGNALIFE (ANR-11-LABX-0028-01) and the “Investments for the future” under Grant ANR-11-INBS-0008 funding the Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure and ANR-10-EQPX-02-01 funding the FlowCyTech facility.
Publisher: Frontiers Media
Keywords: Sublingual immunization
Mucosal antibodies
B Memory response
Neutralization
HIV
Trimeric gp41
Cholera toxin B subunit
URI: http://hdl.handle.net/10481/45202
ISSN: 1664-3224
Rights : Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License
Citation: Bekri, S.; et al. Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates. Frontiers in Immunology, 8: 63 (2017). [http://hdl.handle.net/10481/45202]
Appears in Collections:DQF - Artículos

Files in This Item:

File Description SizeFormat
Bekri_HIVgp41.pdf3.9 MBAdobe PDFView/Open
Recommend this item

This item is licensed under a Creative Commons License
Creative Commons

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! OpenAire compliant DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Feedback

© Universidad de Granada